Shane N. O. Williams
Human Resources Officer bij CENTURY THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Shane N. O. Williams
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Cambridge
239
| College/University | Other Consumer Services | 239 |
| Public Company | Biotechnology | 13 | |
Egon Zehnder International, Inc.
 Egon Zehnder International, Inc. Miscellaneous Commercial ServicesCommercial Services Egon Zehnder International, Inc. provides advisory services. The company is headquartered in New York, NY.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Shane N. O. Williams via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
JPMorgan Investment Management, Inc.
 JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Investment Managers | Head-Equity Investments Head-Fixed Income Invts | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Bar of England & Wales
 Bar of England & Wales Miscellaneous Commercial ServicesCommercial Services Bar of England & Wales represents barristers in England and Wales. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Schroder Investment Management Ltd.
 Schroder Investment Management Ltd. Investment ManagersFinance Schroder Investment Management Ltd. (SIM) is the wholly-owned asset management subsidiary of Schroder International Holdings Ltd., ultimately held by Great Britain-based Schroders Plc (LSE: SDR, ADR: SHNWY). Established in 1985, SIM is headquartered in London and caters to a range of clients such as corporations, insurance firms, local and public authorities, charities, pension funds, high net-worth individuals and retail investors. | Investment Managers | Portfolio Manager-Equities Head-Fixed Income Invts | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Chief Operating Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Amherst College | College/University | Undergraduate Degree Graduate Degree | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
UBS AG (Hong Kong Branch)
 UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| DADA SPA | Internet Software/Services | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
| New York University | College/University | Graduate Degree Graduate Degree | |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| King's College London | College/University | Graduate Degree Undergraduate Degree | |
Lloyds Development Capital (Holdings) Ltd.
 Lloyds Development Capital (Holdings) Ltd. Investment ManagersFinance Lloyds Development Capital (Holdings) Ltd. (LDC) is a private equity firm founded in 1981. The firm is headquartered in London, United Kingdom and is wholly owned by LBG Equity Investments Ltd. | Investment Managers | Private Equity Investor Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The University of Southampton | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Royal Academy of Engineering | College/University | Corporate Officer/Principal Chairman | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| FPT CORPORATION | Information Technology Services | Director/Board Member | |
| Cancer International Research Group | Founder | ||
Pacific Airlines Aviation JSC
 Pacific Airlines Aviation JSC Other TransportationTransportation Pacific Airlines Aviation JSC engages in the operation, management, and provision of airline services. The company was founded on September 24, 1992 and is headquartered in Ho Chi Minh City, Vietnam. | Other Transportation | Chairman | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| VIETNAM DAIRY PRODUCTS | Food: Meat/Fish/Dairy | Director/Board Member | |
| Vietnam National University | College/University | Undergraduate Degree | |
| Hanoi National University of Education | College/University | Graduate Degree | |
State Capital Investment Corp.
 State Capital Investment Corp. Financial ConglomeratesFinance State Capital Investment Corp. (SCIC) is a wholly-owned special economic organization of the Vietnamese Government which was established in 2005 by the Prime Minister of Vietnam to manage and invest state capital in Vietnam's state-owned enterprises and undertake strategic investments in key industries. Located in Hanoi and Ho Chi Minh City, SCIC's primary objectives are to facilitate state-owned enterprise reforms and improve the efficiency of the State's capital utilization. SCIC is mandated to represent State capital interest in various types of businesses and to invest in key sectors with an aim to enhance the dominant economic role of the State subject to market rules. SCIC aims to concentrate investment in key and strategic branches and domains which are a driving force in boosting economic development, paying attention to investment in fruitful and highly profitable branches and domains and reducing investment in branches and domains which the State does not need to control as well as branches and domains which are capable of attracting resources from other economic sectors. SCIC manages a portfolio of SOEs in a range of sectors including financial service, energy, industry, telecommunications, transportation, consumer products, health care, and information technology. | Financial Conglomerates | Corporate Officer/Principal | |
| Vietnam-Oman Investment JSC | Director/Board Member | ||
| Breast Cancer International Research Group Ltd. | Founder | ||
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 24 |
| Verenigd Koninkrijk | 14 |
| Vietnam | 8 |
| Italië | 3 |
| Frankrijk | 2 |
Sectoraal
| Consumer Services | 16 |
| Health Technology | 14 |
| Finance | 10 |
| Commercial Services | 6 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 461 |
| Corporate Officer/Principal | 176 |
| Graduate Degree | 83 |
| Independent Dir/Board Member | 81 |
| Undergraduate Degree | 70 |
Sterkste connecties
| Insiders | |
|---|---|
| John Downing | 41 |
| Simon Holden | 40 |
| Timothy Walbert | 40 |
| Martin Murphy | 33 |
| Joseph Jimenez | 32 |
| Robert Darwent | 28 |
| Shahril Ridza bin Ridzuan | 26 |
| Claudio Corbetta | 24 |
| Georg Müller | 23 |
| Carlo Rizzuto | 22 |
| Michael Majors | 21 |
| Alexander Pasteur | 19 |
| Jonathan Hepple | 19 |
| Tze Chang Lai | 19 |
| Lau Yui Chan | 18 |
- Beurs
- Insiders
- Shane N. O. Williams
- Bedrijfsconnecties
